Hospira Woes Continue As Glass Contamination Spurs Recall

Law360, New York (October 3, 2013, 4:58 PM EDT) -- Beleaguered drugmaker Hospira Inc. on Tuesday said it’s recalling three lots of injectable drugs because the vials contain glass strands that could dislodge and harm patients, the latest addition to a laundry list of recent manufacturing problems for the pharmaceutical giant.

In a statement, Hospira blamed a supplier for defects that it said might cause minor injuries, such as vein inflammation, if glass particulates were to detach from the inner walls of vials and be injected into a patient. It’s also possible that the fragments could...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.